Logo | Name | Σ | ||
---|---|---|---|---|
Amgen #WeareBiotech Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s known today. Our investment in research and development has yielded a robust pipeline that builds on our existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. Amgen is one of 30 companies comprising the Dow Jones Industrial Average®, and part of the Nasdaq-100 Index®. In 2024, Amgen … Sectors: Biotechnology | 1632 | 957 | 333 | |
AbbVie AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, eye care, aesthetics and other areas of unmet need. Learn more about us at www.abbvie.com and review our community guidelines at https://www.abbvie.com/social-media-community-guidelines.html. Biopharmaceutical, Biotechnology, Innovation, Research and Development, Manufacturing, Biotherapeutics, Oncology, Immunology, Virology, Neuroscience, Womens Health, Aesthetics, and Eye Care Sectors: Pharmaceutical | 959 | 787 | 130 | |
UK Research and Innovation Transforming Tomorrow Together UK Research and Innovation (UKRI) is the public sector organisation that invests £8 billion annually to support the entire research and innovation system. We strive for a society powered and empowered by research and innovation, with economic, social, environmental and cultural benefits for all. We invest in people, places, ideas, innovation and impacts, empowering researchers, innovators and entrepreneurs to turn the many challenges we all face into opportunities, driving up prosperity and wellbeing across the UK and globally. The impacts of our work are felt right across society. We enrich lives by increasing our understanding of ourselves … Sectors: Public business cluster | 4059 | 2874 | 696 | |
Sofinnova Partners Sofinnova Partners is a leading European VC firm in life sciences, specializing in healthcare and sustainability. Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise. Sofinnova Partners is a hands-on company builder across the entire value chain of life sciences investments, from seed to later-stage. The firm actively partners with ambitious entrepreneurs as a lead or cornerstone investor to develop transformative innovations that have the potential … | 401 | 203 | 213 | |
Sanofi We are Sanofi, an innovative global healthcare company. We chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms vaccines, rare diseases, rare blood disorders, neurology, immunology, oncology, diabetes, cardiovascular diseases, and consumer healthcare Tags: CAC40 Sectors: Pharmaceutical | 3559 | 2655 | 836 | |
European Space Agency - ESA The European Space Agency (ESA) is Europe’s gateway to space. Its mission is to shape the development of Europe’s space capability and ensure that investment in space continues to deliver benefits to the citizens of Europe and the world. ESA is an international organisation with 22 Member States. By coordinating the financial and intellectual resources of its members, it can undertake programmes and activities far beyond the scope of any single European country. ESA's 22 Member States are Austria, Belgium, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Luxembourg, the Netherlands, Norway, Poland, Portugal, Romania, Spain, Sweden, … Sectors: Defence and Aerospace | 4580 | 3516 | 352 | |
France Biotech Entrepreneurs in HealthTech Created in 1997, the association is the French non-profit organization that brings together the country's leading innovative health compagnies and their expert partners (investors, lawyers, research institutes, cluster, etc...). Its core mission is to promote health innovation in France and help the sector's start-up companies and SMEs to become tomorrow's leaders able to rapidly develop new therapeutic solutions. Our Missions: To support innovative start-ups and SMEs of the HealthTech industry (biotech, medtech, digital health, big data) by tackling four major issues: - Financial: encourage investment in health innovation - Tax: ensure fiscal stability - Administrative and regulatory: … Sectors: Biotechnology Startup accelerator & VC | 880 | 513 | 530 | |
Intuitive A global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery. Intuitive (Nasdaq: ISRG), headquartered in Sunnyvale, Calif., is a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery. At Intuitive, we believe that minimally invasive care is life-enhancing care. Through ingenuity and intelligent technology, we expand the potential of physicians to heal without constraints. Robotics, Medical Devices, minimally invasive surgery, robotic-assisted surgery, robotic surgery, lung biopsy, and endoluminal system Sectors: Medical Device | 223 | 142 | 39 | |
Nasdaq At Nasdaq, our purpose is to advance economic progress for all. At Nasdaq, our purpose is to advance economic progress for all. We power stronger economies, create more equitable opportunities, and contribute to a more sustainable world to help our communities, clients, employees, and people of all backgrounds reach their full potential. Meet the #NasdaqFam and learn about our purpose, culture and careers here: https://www.nasdaq.com/about/careers Technology Solutions, Financial Markets, Global Trading, Equities, Market Technology, Market Services, Fixed Income, Derivatives, Corporate Solutions, Global Index Services, Listing Services, and Nasdaq MarketSite Sectors: Finance | 6715 | 5020 | 1170 | |
PwC At PwC, our purpose is to build trust in society and solve important problems. We’re a network of firms in 152 countries with over 327,000 people who are committed to delivering quality in assurance, advisory and tax services. Find out more and tell us what matters to you by visiting us at www.pwc.com. PwC refers to the PwC network and/or one or more of its member firms, each of which is a separate legal entity. Content on this page has been prepared for general information only and is not intended to be relied upon as accounting, tax or professional advice. … Sectors: Consulting, audit | 5535 | 4860 | 302 | |
Dia & Co The Challenge: 67% of American women wear sizes 14+—that’s 100 million women. Yet this majority is systematically underserved by the retail industry. The plus size community faces paltry options, unwelcoming environments, and a lack of representation—all adding up to a disappointing experience with style. Our Vision: Style freedom through a life well-lived The Dia & Co Solution: Dia & Co is the only retail service dedicated to meeting the plus size community’s full range of style needs. We’re applying the best of data and technology to serve women who have been ignored for far too long—from developing the shopping experiences … Sectors: Semiconductors | 2360 | 1871 | 335 | |
MSD At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse … Sectors: Pharmaceutical | 2127 | 1874 | 191 | |
London Stock Exchange The London Stock Exchange is at the heart of where ideas meet capital and become reality. Home to nearly 2,000 companies from over 100 countries, with a combined value of £4.8 trillion. Whether you’re a business seeking greater horizons, a government with an ambitious sustainability agenda, a pension fund seeking returns for your client, we provide the flexibility to make the connections you need to create real impact. We offer our customers extensive access to capital markets and liquidity across multiple asset classes. We operate a broad range of international equity, fixed income and exchange traded products. The London Stock … Sectors: Finance | 1699 | 1085 | 193 | |
General Electric A new era is here, and we want you to be a part of it. We will now be sharing our content on our respective GE Aerospace and GE Vernova pages. Be sure to follow each to keep up with the future of aviation and energy. Oil & Gas, Healthcare, Intelligent Platforms, Renewable Energy, Transportation, Aviation, Digital, Lighting, Power, and Energy Management Sectors: Building supplies | 4912 | 3122 | 666 | |
Bristol Myers Squibb At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experience. Join us and pursue innovative ideas alongside some of the brightest minds in biopharma, collaborating with a team rich in diversity of experiences, and perspectives. We have built a sustainable pipeline of potential therapies and are leveraging translational medicine and data analytics to understand how we can deliver the right medicine to the right patient, at the right time, to achieve the best outcome. Whether in a scientific, business or supporting function, … Sectors: Pharmaceutical | 1681 | 1089 | 129 | |
Financial Times About the Financial Times The Financial Times is one of the world’s leading business news organisations, recognised internationally for its authority, integrity and accuracy. The FT has a record paying readership of one million, three-quarters of which are digital subscriptions. It is part of Nikkei Inc., which provides a broad range of information, news and services for the global business community. Learn more about the FT, including announcements and career opportunities, at aboutus.ft.com. Subscribe at subs.ft.com. One of the world’s leading business news organisations Sectors: Media | 10753 | 9494 | 476 | |
Elsevier Because informed decisions lead to better outcomes As a global leader in information and analytics, Elsevier helps researchers and healthcare professionals advance science and improve health outcomes for the benefit of society. We do this by facilitating insights and critical decision-making for customers across the global research and health ecosystems. In everything we publish, we uphold the highest standards of quality and integrity. We bring that same rigor to our information analytics solutions for researchers, health professionals, institutions and funders. Elsevier employs 8,700 people worldwide. We have supported the work of our research and health partners for more than 140 … Sectors: Publishing | 664 | 539 | 108 | |
Deep Science Ventures We are creating a future where humanity and the planet can thrive (and we're hiring!) Deep Science Ventures is a venture creator, combining available scientific knowledge and founder-type scientists into high-impact ventures, to build a future where humanity and the planet thrive. We operate in 4 sectors: Pharmaceuticals, Climate, Agriculture and Computation, tackling the challenges defining those areas by taking a first principles approach and partnering with leading institutions. Visit our website for more information. Science Venture Building, Climate, Agriculture, Pharma, and Computation Sectors: Startup accelerator & VC | 102 | 51 | 49 | |
Oxford Science Enterprises We find, fund and build transformational businesses via our unique partnership with the University of Oxford Oxford Science Enterprises (OSE) is an independent, billion-pound investment company, created in 2015 to find, fund and build transformational businesses across specialist areas of life sciences, health tech, AI, new compute, climate tech and agtech. Via our unique partnership with the University of Oxford, the world's #1 research university, we turn the world's most advanced science and technology into companies tackling the world's toughest challenges. In nine years, we have invested £0.7 billion in over 120 ambitious companies built on Oxford science. A key … Sectors: Startup accelerator & VC | 281 | 104 | 126 | |
Biogen Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients’ lives and to create value for shareholders and our communities. We apply deep understanding of human biology and leverage different modalities, to advance first-in-class treatments or therapies that deliver superior outcomes. Our approach is to take bold risks, balanced with return on investment to deliver long-term growth. With approximately 7,000 people worldwide, we are truly a global organization, headquartered in Cambridge, Massachusetts, which is also home to our research operations. Our international headquarters are based in Baar, Switzerland and we … Sectors: Biotechnology | 703 | 488 | 51 | |
Barclays Wealth Management Wealth Management with a wealth of experience. Follow us for news, updates and expert insights. Barclays provides wealth management expertise to our clients in the UK. Our regional network of financial experts across the UK are available to help clients to manage their wealth effectively. To find out more about our services, careers and insights at Barclays Wealth Management please explore our website here: https://www.barclays.co.uk/wealth-management/ Banking Services, Credit Services including Mortgages, Investment Management, Financial Planning, Brokerage, Wealth Management, and Private Banking Sectors: Bank | 2024 | 1789 | 44 | |
Johnson & Johnson At Johnson & Johnson, we believe health is everything. As a focused healthcare company, with expertise in Innovative Medicine and MedTech, we’re empowered to tackle the world’s toughest health challenges, innovate through science and technology, and transform patient care. All of this is possible because of our people. We’re passionate innovators who put people first, and through our purpose-driven culture and talented workforce, we are stronger than ever. Learn more at https://www.jnj.com. Community Guidelines: http://www.jnj.com/social-media-community-guidelines Health Care, Medical Devices & Diagnostics, and Pharmaceuticals Sectors: Pharmaceutical | 4582 | 2935 | 643 | |
EY EY is building a better working world by creating new value for clients, people, society, the planet, while building trust in the capital markets. Enabled by data, AI and advanced technology, EY teams help clients shape the future with confidence and develop answers for the most pressing issues of today and tomorrow. EY teams in more than 150 countries work across a full spectrum of services in assurance, consulting, tax, strategy and transactions, strengthened by sector experience and diverse ecosystem partners. Find out more about the EY global network: http://ey.com/en_gl/legal-statement Advisory, Assurance, Tax, Transactions, Audit, Mergers, M&A, Financial Services, Accounting, … Sectors: Consulting, audit | 5688 | 4241 | 1053 | |
UK Export Finance We help UK companies of all sizes win contracts, fulfil orders and get paid. UK Export Finance is the UK’s export credit agency and a government department, working alongside the Department for Business and Trade as an integral part of its strategy and operations. Our mission is to advance prosperity by ensuring no viable UK export fails for lack of finance or insurance, doing that sustainably and at no net cost to the taxpayer. We help UK companies of all sizes and in all sectors win, fulfil and get paid for export contracts. Export finance and insurance Sectors: National and local authorities | 3599 | 2711 | 451 | |
EU Green Capital The official #EUGreenCapital and #EUGreenLeaf Awards. Our aim is to improve Europe's urban environment. The European Green Capital and European Green Leaf awards are a European Commission initiative to recognise a city's commitment to a better urban environment. Cities with populations over 100,000 inhabitants are eligible to apply for the European Green Capital Award while the European Green Leaf is open to cities of between 20,000 and 100,000 inhabitants. Winners demonstrate well-established records of high environmental standards and a commitment to setting ambitious goals for future environmental progress, underpinned by the practical application of sustainable development. The schemes have a … Sectors: European Union | 10599 | 7638 | 1329 | |
CMS Francis Lefebvre Avocats Notre cabinet d’avocats dispose d’une grande expertise dans de nombreux secteurs d’activité dans plus de 45 pays. CMS Francis Lefebvre Avocats is one of the leading international corporate law firms. It is ranked 2nd largest law firm in France by revenue. Its deep roots, unique positioning and highly recognised expertise enable it to deliver innovative, high-value-added solutions in Tax, Business, Corporate and Employment law. CMS Francis Lefebvre Avocats is a member of CMS. Founded in 1999, CMS, with more than 74 offices in 42 countries across the world, is the 3rd international law firm. Employing over 4,500 lawyers, CMS has … Sectors: Law Practice | 753 | 386 | 393 | |
KPMG KPMG is a global network of professional firms providing Audit, Tax and Advisory services. We have 273,000 outstanding professionals working together to deliver value in 143 countries and territories. With a worldwide presence, KPMG continues to build on our successes thanks to clear vision, defined values and, above all, our people. Our industry focus helps KPMG firms’ professionals develop a rich understanding of clients' businesses and the insight, skills and resources required to address industry-specific issues and opportunities. The independent member firms of the KPMG network are affiliated with KPMG International Cooperative (“KPMG International”), a Swiss entity. Each KPMG firm … Sectors: Consulting, audit | 6623 | 5606 | 673 | |
Takeda Better Health, Brighter Future We strive to transform lives. While the science we advance is constantly evolving, our core purpose is enduring. For more than two centuries, our values have guided us to do what’s right for patients and for society. We know that changing lives requires us to do things differently. We start by listening to and addressing what really matters to patients, the people who love them, and those in the healthcare system who provide care. And that’s what inspires us all to be bold, push boundaries and set new standards that open up greater opportunities. Read our … Sectors: Pharmaceutical | 1008 | 716 | 265 | |
JLL We’re a leading professional services firm that specializes in real estate and investment management. JLL shapes the future of real estate for a better world by using the most advanced technology to create rewarding opportunities, amazing spaces and sustainable real estate solutions for our clients, our people and our communities. We want the most ambitious clients to work with us, and the most ambitious people to work for us. Join us. tenant representation, real estate, property, financial services, investment, corporate solutions, capital markets, outsourcing, commercial property, and sustainability Sectors: Real Estate | 2421 | 1268 | 980 | |
Ipsen We are a global biopharmaceutical company with a focus on bringing transformative medicines to patients in three therapeutic areas: Oncology, Rare Disease and Neuroscience. Our pipeline is fueled by external innovation and supported by nearly 100 years of development experience and global hubs in the U.S., France and the U.K. Our teams in more than 40 countries and our partnerships around the world enable us to bring medicines to patients in 88 countries. For more information, visit ipsen.com. Pauta exclusiva para México: Clave de Autorización COFEPRIS: 243300201B1962 CONSULTE A SU MÉDICO. Pharmaceuticals, Specialty care: oncology, neuroscience, endocrinology, Research: peptides, toxins, … Sectors: Pharmaceutical | 403 | 346 | 58 | |
EY Pythagoras This page is no longer being updated. We are now EY Pythagoras. Follow the EY LinkedIn page here: https://www.linkedin.com/company/ernstandyoung/ to keep up to date with our news, events and technical consulting offerings. CRM, Microsoft Dynamics 365 Consultancy, training, support, SharePoint, SharePoint Consultancy, training, support, Office 365, Office 365 Consultancy, training, support, Yammer, Power BI, Microsoft Dynamics 365, Azure, Power Apps, and Power Platform | 8270 | 6773 | 3276 | |
Amazon Web Services (AWS) Official Global LinkedIn page for Amazon Web Services (AWS). Launched in 2006, Amazon Web Services (AWS) began exposing key infrastructure services to businesses in the form of web services -- now widely known as cloud computing. The ultimate benefit of cloud computing, and AWS, is the ability to leverage a new business model and turn capital infrastructure expenses into variable costs. Businesses no longer need to plan and procure servers and other IT resources weeks or months in advance. Using AWS, businesses can take advantage of Amazon's expertise and economies of scale to access resources when their business needs them, … Sectors: IT services | 7684 | 6944 | 142 | |
Illumina For Startups Illumina for Startups supporting genomics and multi-omics startups across the globe. Illumina for Startups Network aims to inspire the creation, funding, and growth of genomics and multi-omics startups across the globe. It is designed for the entrepreneurial ecosystem and focused on building connections, strengthening community, and advancing breakthrough genomics applications. Current Illumina for Startups initiatives include Startups Grants for founders to work with Illumina sites to run proof-of-concept sequencing experiments. For more information visit https://www.illumina.com/company/illumina-for-startups.html Past initiatives include Illumina Accelerator, company creation engine co-located with Illumina research and development sites in San Francisco Bay Area and Cambridge, UK. Illumina Accelerator … Sectors: Biotechnology Startup accelerator & VC | 917 | 456 | 155 | |
IP Group plc Visionary ventures IP Group accelerates the impact of science for a better future. As the most active UK based, early-stage science investor, we develop and support some of the world’s most exciting businesses in deeptech, life sciences and cleantech (led by Kiko Ventures). Through Parkwalk, the UK's largest growth EIS fund manager, we also back world-changing innovation emerging in leading universities and research institutions. Our specialist investment team combines sector expertise with an international approach. Together we have a strong track record of success, having backed high-profile companies including Oxford Nanopore Technologies plc, First Light Fusion, Hysata, and Oxbotica. IP … | 255 | 87 | 168 | |
McKinsey & Company We accelerate sustainable and inclusive growth. McKinsey & Company is a global management consulting firm. We are the trusted advisor to the world's leading businesses, governments, and institutions. We work with leading organizations across the private, public and social sectors. Our scale, scope, and knowledge allow us to address problems that no one else can. We have deep functional and industry expertise as well as breadth of geographical reach. We are passionate about taking on immense challenges that matter to our clients and, often, to the world. We work with our clients as we do with our colleagues. We build … Sectors: Consulting | 4848 | 4127 | 673 | |
IBM At IBM, we do more than work. We create. We create as technologists, developers, and engineers. We create with our partners. We create with our competitors. If you're searching for ways to make the world work better through technology and infrastructure, software and consulting, then we want to work with you. We're here to help every creator turn their "what if" into what is. Let's create something that will change everything. Cloud, Mobile, Cognitive, Security, Research, Watson, Analytics, Consulting, Commerce, Experience Design, Internet of Things, Technology support, Industry solutions, Systems services, Resiliency services, Financing, and IT infrastructure Sectors: IT services | 15921 | 10776 | 537 | |
NHS England We lead and support the NHS in England to deliver improved care for patients. We work with NHS Improvement to act as a single organisation to better support the NHS to deliver improved care for patients: https://www.england.nhs.uk/comment-policy NHS England is increasing transparency in the NHS and improving services for patients. We work with NHS staff, patients, stakeholders and the public to improve the health outcomes for people in England. We are responsible for the stewardship of £99 billion of public funds to provide comprehensive health and care services available to all, where there is clinical need and regardless of an … Sectors: Insurance | 2052 | 1739 | 94 | |
Syneos Health Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. We bring together a talented team of professionals with a deep understanding of patient and physician behaviors and market dynamics. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. Syneos Health supports a diverse, equitable and inclusive culture that cares for colleagues, customers, patients, communities and the environment. Clinical Trials and Biopharmaceutical Product Lifecycle Management Sectors: Pharmaceutical | 143 | 126 | 20 | |
Gilead Sciences Creating Possible At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. From our pioneering virology medicines to our growing impact in oncology, we're delivering innovations once thought impossible in medicine. Our focus goes beyond medicines, and we also strive to remedy health inequities and break down barriers to care. We empower our people to tackle these challenges, and we’re all united in our commitment to help millions of people live healthier lives. Social Media Guidelines: https://www.gilead.com/social-media-guidelines Sectors: Biotechnology Pharmaceutical | 822 | 637 | 70 | |
Cambridge Enterprise Helping to commercialise research from the University of Cambridge for the benefit of society worldwide. Cambridge Enterprise is the commercialisation arm of the University of Cambridge. At Cambridge Enterprise, we help University of Cambridge members create beneficial impact from their research and expertise that can change the world, through academic consultancy, intellectual property management, development and licensing, venture building, venture funding and convening and connecting the wider Cambridge innovation ecosystem. Our success is measured in the success of our University partners as they bring their work to market, be it ground-breaking stem cell research, critical suspension technology used in Formula … Sectors: Startup accelerator & VC | 243 | 128 | 92 | |
Oxford University Innovation Building a world-leading innovation ecosystem with Oxford University at its heart. Oxford University Innovation Limited is wholly owned by the University of Oxford. The company mission is to be the leading international technology transfer organisation, to transfer technology and expertise from the University of Oxford, to deliver value to all our clients, and to maximise social and economic benefits in a commercial manner. Oxford University Innovation helps staff and students to apply their expertise and research for wider social and economic benefit. Our role is to help University staff and students bring the benefits of their research and expertise to … Sectors: Research | 189 | 78 | 80 | |
PharmaTimes Media Ltd Kickstarting healthcare conversations. Kickstarting healthcare conversations. PharmaTimes Magazine is the leading pharmaceutical magazine for senior decision makers in the pharma and healthcare industries. It is recognised for its wide-ranging coverage of the key developments facing this fast-paced sector, and its analytical, independent content. PharmaTimes Magazine has a dedicated staff of writers and editors who have many years' experience in writing and editing copy for pharma and healthcare readers in national newspapers, magazines and online. PharmaTimes Magazine readers range from pharmaceutical executives, to healthcare professionals (chief pharmacists, medicines management, academic health science networks and NHS commissioners), to government ministers. Available in … Sectors: Pharmaceutical | 110 | 104 | 9 | |
GSK We are uniting science, technology and talent to get ahead of disease together. Our community guidelines: https://gsk.to/socialmedia Pharmaceutical products and Vaccines Sectors: Pharmaceutical | 1120 | 735 | 402 | |
Novartis Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Find out more at https://www.novartis.com See our community guidelines: https://go.novartis.social/3Nboxki Cardiovascular, Immunology, Neuroscience, Solid Tumors, Hematology, Chemistry, xRNA, Radioligand, and Gene and cell therapy Sectors: Pharmaceutical | 1796 | 1591 | 123 | |
Bayer Bayer is a global enterprise with core competencies in the life science fields of healthcare and nutrition. We design our products and services to serve the most essential human needs of health and nutrition. At the same time, we strive to address some of the world’s biggest challenges presented by a growing and aging global population. At Bayer, we’re committed to driving sustainable development and generate a positive impact with our businesses. Through the power of science, we’re pioneering new possibilities that advance life for all of us. That means reimagining how we care for ourselves and one another by … Tags: DAX30 Sectors: Chemistry Pharmaceutical | 4776 | 2933 | 638 | |
techUK Championing tech's role in preparing and empowering the UK for what comes next and delivering a better future for all. techUK is a membership organisation that brings together people, companies and organisations to realise the positive outcomes of what digital technology can achieve in collaboration with our sister company TechSkills.org. We collaborate across business, government and stakeholders to fulfil the potential of technology to deliver a stronger society and more sustainable future. By providing expertise and insight, we support our members, partners and stakeholders as they prepare the UK for what comes next in a constantly changing world. Trade association … Sectors: National and local authorities | 2387 | 1193 | 719 | |
United Airlines Good Leads The Way. This is the story of airline that leads the industry from ground to clouds. Our global cast of over 100,000+ hero characters are each on a journey to be a force for good for our customers, the planet and each other. Come be part of this story. Airline, Travel, Air Cargo, Air Travel, Information Technology, customer service, aviation, technology, and digital technology Sectors: Transport | 3351 | 2658 | 139 | |
United Nations Office for Disarmament Affairs Aiming to promote nuclear disarmament and non-proliferation and the strengthening of the disarmament regimes. The Office for Disarmament Affairs supports multilateral efforts aimed at achieving the ultimate goal of general and complete disarmament under strict and effective international control. Sectors: International development | 16279 | 13116 | 681 | |
Pfizer We’re celebrating 175 years of daring scientific innovation—and we’re not done yet. Every day, we’re channeling our passion and resources into delivering innovative therapies that change the face of healthcare. Let’s outdo yesterday. Follow our progress as we accelerate the next generation of cancer treatments at LetsOutdoCancer.com For additional information on our guidelines, please visit http://www.pfizer.com/community-guidelines To apply science and our global resources to improve health and well-being at every stage of life. We strive to provide access to safe and effective and affordable medicines and health care services to the people who need them. Sectors: Pharmaceutical | 1417 | 1102 | 137 | |
AstraZeneca We're transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet. For more information, visit www.astrazeneca.com. Community Guidelines: bit.ly/2MgAcio Pharmaceutical, Biopharmaceutical, Innovation, Research and development, and Global business Sectors: Pharmaceutical | 3849 | 2669 | 204 |